Bipolar therapeutics: a unified model?

Written by Lauren Pulling

We recently featured the review ‘Inositol depletion, GSK3 inhibition and bipolar disorder’ from our partner journal, Future Neurology. This #NCMentalHealthMonth, we speak to the paper’s authors, Miriam Greenberg and Wenxi Yu, both from Wayne State University (WSA; WA, USA). The authors discuss the current hypotheses surrounding the therapeutic mechanisms of anti-bipolar drugs, as well as their hopes for the future of the field of bipolar disorder therapeutics. First, please could you tell us a little about your research background and what led you to become interested in the therapeutic mechanisms of inositol-depleting drugs in bipolar disorder? Miriam Greenberg: My interest...

To view this content, please register now for access

It's completely free